CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
2.520
+0.010 (0.40%)
At close: Sep 24, 2026, 4:00 PM EDT
2.570
+0.050 (1.98%)
After-hours: Sep 24, 2026, 7:58 PM EDT
CervoMed Market Cap
CervoMed has a market cap or net worth of $38.1 million as of September 24, 2026. Its market cap has decreased by -50.03% in one year.
Market Cap
38.10M
Enterprise Value
13.16M
1-Year Change
-50.03%
Ranking
Category
Stock Price
$2.52
ChartMarket Cap Chart
Since August 17, 2023, CervoMed's market cap has decreased from $43.26M to $38.10M, a decrease of -11.93%. That is a compound annual growth rate of -4.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 38.10M | -47.88% |
| Dec 31, 2025 | 73.10M | 278.47% |
| Dec 31, 2024 | 19.31M | -55.39% |
| Dec 29, 2023 | 43.30M | 0.08% |
| Aug 17, 2023 | 43.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Filana Therapeutics | 42.03M |
| Veru Inc. | 41.94M |
| Lite Strategy | 40.15M |
| Karyopharm Therapeutics | 39.69M |
| Seres Therapeutics | 37.68M |
| Actinium Pharmaceuticals | 37.10M |
| aTyr Pharma | 36.80M |
| Context Therapeutics | 35.15M |